Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186015197> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W3186015197 endingPage "145" @default.
- W3186015197 startingPage "134" @default.
- W3186015197 abstract "Introduction: Cisplatin is one of the most widely used drugs for the treatment of various cancers but has oxidative tissue damage as one of its side effects. This study investigated the oxidative stress profile in some important body tissues following the co-administration of cisplatin (CIS) and resveratrol (RSV). Methods: Thirty-five adult female rats with an average body weight of 162g were divided into 5 groups (n=7) and used for this experimental study. Group A served as the normal control group and received distilled water only. Group B received only a single dose intraperitoneal injection of 10mg/kg CIS. Groups C, D and E were orally given 5, 10 and 20mg/kg of RSV respectively for 7 days, starting 24h after a single CIS dose intraperitoneal injection of 10mg/kg. Selected body tissues were harvested for oxidative stress profiling at the end of the experiment. Results: CIS significantly increased malondialdehyde levels and decreased glutathione, superoxide dismutase and catalase levels in all the tissues assessed (ovary, uterus, liver, kidney, pancreas, stomach and spleen) when compared to the normal control. The RSV treatment caused the reversal of these effects; malondialdehyde levels were significantly decreased, while glutathione, superoxide dismutase and catalase levels were significantly increased across all the examined tissues. Conclusion: RSV at different doses could be effective in the management of CIS-induced oxidative stress and lipid peroxidation across some body tissues. However, this effect may be dependent on the dose of CIS and RSV." @default.
- W3186015197 created "2021-08-02" @default.
- W3186015197 creator A5036694227 @default.
- W3186015197 date "2021-07-01" @default.
- W3186015197 modified "2023-10-16" @default.
- W3186015197 title "Oxidative stress profile following the co-administration of cisplatin and resveratrol in female rats: a preliminary study" @default.
- W3186015197 cites W1996202908 @default.
- W3186015197 cites W2001331638 @default.
- W3186015197 cites W2132779083 @default.
- W3186015197 cites W2149918525 @default.
- W3186015197 cites W2314753133 @default.
- W3186015197 cites W2336732799 @default.
- W3186015197 cites W2790413853 @default.
- W3186015197 doi "https://doi.org/10.32598/ppj.25.2.90" @default.
- W3186015197 hasPublicationYear "2021" @default.
- W3186015197 type Work @default.
- W3186015197 sameAs 3186015197 @default.
- W3186015197 citedByCount "0" @default.
- W3186015197 crossrefType "journal-article" @default.
- W3186015197 hasAuthorship W3186015197A5036694227 @default.
- W3186015197 hasBestOaLocation W31860151971 @default.
- W3186015197 hasConcept C126322002 @default.
- W3186015197 hasConcept C134018914 @default.
- W3186015197 hasConcept C181199279 @default.
- W3186015197 hasConcept C185592680 @default.
- W3186015197 hasConcept C2775838275 @default.
- W3186015197 hasConcept C2776151105 @default.
- W3186015197 hasConcept C2778401633 @default.
- W3186015197 hasConcept C2778979269 @default.
- W3186015197 hasConcept C2780091579 @default.
- W3186015197 hasConcept C2780159080 @default.
- W3186015197 hasConcept C2780829032 @default.
- W3186015197 hasConcept C538909803 @default.
- W3186015197 hasConcept C55493867 @default.
- W3186015197 hasConcept C71924100 @default.
- W3186015197 hasConcept C98274493 @default.
- W3186015197 hasConceptScore W3186015197C126322002 @default.
- W3186015197 hasConceptScore W3186015197C134018914 @default.
- W3186015197 hasConceptScore W3186015197C181199279 @default.
- W3186015197 hasConceptScore W3186015197C185592680 @default.
- W3186015197 hasConceptScore W3186015197C2775838275 @default.
- W3186015197 hasConceptScore W3186015197C2776151105 @default.
- W3186015197 hasConceptScore W3186015197C2778401633 @default.
- W3186015197 hasConceptScore W3186015197C2778979269 @default.
- W3186015197 hasConceptScore W3186015197C2780091579 @default.
- W3186015197 hasConceptScore W3186015197C2780159080 @default.
- W3186015197 hasConceptScore W3186015197C2780829032 @default.
- W3186015197 hasConceptScore W3186015197C538909803 @default.
- W3186015197 hasConceptScore W3186015197C55493867 @default.
- W3186015197 hasConceptScore W3186015197C71924100 @default.
- W3186015197 hasConceptScore W3186015197C98274493 @default.
- W3186015197 hasIssue "2" @default.
- W3186015197 hasLocation W31860151971 @default.
- W3186015197 hasOpenAccess W3186015197 @default.
- W3186015197 hasPrimaryLocation W31860151971 @default.
- W3186015197 hasRelatedWork W2038022415 @default.
- W3186015197 hasRelatedWork W2041257525 @default.
- W3186015197 hasRelatedWork W2066642331 @default.
- W3186015197 hasRelatedWork W2157639809 @default.
- W3186015197 hasRelatedWork W2158849542 @default.
- W3186015197 hasRelatedWork W2183540883 @default.
- W3186015197 hasRelatedWork W2889329188 @default.
- W3186015197 hasRelatedWork W2958374161 @default.
- W3186015197 hasRelatedWork W4285037963 @default.
- W3186015197 hasRelatedWork W4313039917 @default.
- W3186015197 hasVolume "25" @default.
- W3186015197 isParatext "false" @default.
- W3186015197 isRetracted "false" @default.
- W3186015197 magId "3186015197" @default.
- W3186015197 workType "article" @default.